News


Highlights of celebrating 10 years Immuno Valley at the Annual Conference 2018


We look back on a very successful Immuno Valley Conference 2018 which took place on September, 25th. National and international speakers presented the latest scientific breakthroughs, including innovative technologies and promising new products in the field of infectious and inflammatory diseases.

We welcomed over academic and business 120 participants active in the field of Infectious and inflammatory diseases.

 

 

The Immuno Valley Annual Conference 2018 started with a retrospective of 10 years Immuno Valley, followed by keynote presentations from prof. Mihai Netea, about Trained immunity and prof. Frederic Rousseau, about targeted protein aggregation.

In addition parallel sessions provided excellent presentations about vaccines, nutrition, alternative therapeutics and diagnostics, given by innovators in public and private organisations: CureVac, Bunyavax, Wageningen University, GlaxoSmithKline, BaseClear, Lallemand Health Solutions, Micreos, TNO, Dopharma, ACTA, Helia Biomonitoring, Eindhoven University of Technology, X-Heal Diagnostics and the Radboud University Medical Center. 

Ultimately, through our partnering and networking activities, we facilitated in establishing new valuable connections.

Many thanks to our speakers and participants for a fruitful and very inspiring day.

 

 

 

 

Photo credit: Dave Sharman, Sharman Images

 

 

  1. More news

  2. All about the Immuno Valley Annual Conference 2018: Bringing together innovators in science, technology and business. Looking forward to meeting you too!

    The Immuno Valley Annual Conference is organised on 25 September 2018, at the Railway Museum, Utrecht, the Netherlands. At this Annual Conference we are also looking forward to celebrate our 10th Immuno Valley anniversary!


  3. Record amount of Measles cases in the European Region

    The World Health Organization (WHO) reported a dramatic increase in measles cases in 2018. In the first 6 months of 2018, more than 41,000 children and adults in the WHO European Region have been infected with measles, compared with 23,927 cases throughout 2017. This is an exponential increase, which could have been prevented if people go and get their vaccinations in time. As Zsuzsanna Jakab, WHO regional director for Europe, said in a statement: ‘Good health for all starts with immunization’.


  4. Micreos ‘Alternative to antibiotics’ winner of Ideas from Europe competition

    On April 26, 2018, Micreos was chosen as Europe’s most relevant innovation at the finals of the EU’s Ideas from Europe competition. Ideas from Europe is a European initiative that facilitates sustainable innovations aimed at global challenges.


  5. Proud to present our Annual Conference Speakers

    Top international speakers from academic institutions and businesses will let you explore developments and a forward look in diagnostics, prevention and treatment of inflammatory and infectious diseases in humans and animals .


  6. EXPLORA Consortium/Immuno Valley have entered the last phase of evaluation of 2017/2018 NWO ‘Perspectief’

    The EXPLORA Consortium focusses on personalized diagnostics and interventions in chronic inflammatory diseases.